Correlations between progression of coronary artery disease and circulating endothelial progenitor cells

Carlo Briguori1, Ugo Testa, Roberta Riccioni

  • 1Laboratory of Interventional Cardiology, Clinica Mediterranea, Naples, Italy. carlobriguori@clinicamediterranea.it

Insights

Low levels of circulating endothelial progenitor cells (EPCs) predict coronary artery disease (CAD) progression. This finding highlights EPCs as potential biomarkers for monitoring CAD development in patients with non-significant stenosis.

Area of Science:

  • Cardiovascular Medicine
  • Cell Biology
  • Regenerative Medicine

Background:

  • The progression of coronary artery disease (CAD) remains incompletely understood.
  • Endothelial progenitor cells (EPCs) are implicated in vascular repair and may play a role in CAD pathophysiology.

Purpose of the Study:

  • To investigate the relationship between circulating endothelial progenitor cell (EPC) levels and the 24-month progression of non-significant coronary artery lesions.
  • To identify predictors of CAD progression in patients undergoing percutaneous coronary intervention.

Main Methods:

  • An observational cohort study involving 136 patients with non-significant coronary artery stenosis (<50% diameter stenosis).
  • Analysis of circulating EPC populations including CD34(+), CD133(+), CD34(+)/KDR(+), CD34(+)/VE cadherin(+), and endothelial cell colony-forming units (CFU-ECs).
  • Coronary angiography was used to assess lesion progression (>15% diameter stenosis increase) at 24 months.

Main Results:

  • Significant CAD progression was observed in 42% of patients (57 out of 136) at 24 months.
  • Independent predictors of progression included elevated LDL cholesterol (>100 mg/dl), male sex, and low plasma levels of CFU-ECs.
  • Patients with angiographic CAD progression exhibited significantly lower circulating EPC levels.

Conclusions:

  • Circulating EPC levels, particularly CFU-ECs, are significantly lower in patients experiencing CAD progression.
  • Low EPC levels, elevated LDL cholesterol, and male sex are associated with increased risk of coronary artery lesion progression.
  • EPCs may serve as valuable biomarkers for predicting CAD progression in individuals with existing coronary artery disease.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...